Contact Information:

Media Contact

Haley Bridger
hbridger@partners.org
617-525-6383

Twitter: BrighamWomens

http://www.brighamandwomens.org




Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości.

PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION
RSS - Press News Release
Add Press Release

Melatonin and multiple sclerosis: Why MS symptoms may improve as the days get shorter

New research from Brigham and Women's Hospital offers an answer to the MS 'seasonal paradox'


2015-09-10
(Press-News.org) For patients and clinicians alike, it's long been a mystery: why do symptoms of multiple sclerosis (MS) seem to get better in the winter and worse in the summer? A group led by Francisco Quintana, PhD, at the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital (BWH) and collaborators have found an explanation that could lead to a deeper understanding of the disease and more targeted treatment options for patients. By first looking broadly at possible environmental factors and then deeply at preclinical models of MS, the research team found that melatonin - a hormone involved in regulating a person's sleep-wake cycle - may influence MS disease activity. The team reports its findings this week in Cell.

The researchers caution that this work does not mean MS patients should start taking supplements of melatonin - an imperfect drug. Instead, this new approach - which takes its lead from environmental observations - can be seen as a first step toward better and more targeted therapies.

"We know that for multiple sclerosis and most autoimmune diseases, both genetic and environmental factors play an important role, but in the last decade or so, most research has focused only on the genetic side of the equation," said co-corresponding author Quintana, associate professor in the Ann Romney Center for Neurologic Diseases at BWH. "But we wanted to see what environmental factors would reveal to us about this disease. We knew that MS disease activity changed with the seasons. What we've uncovered offers an explanation for why that is the case."

Working closely with colleagues at the Center for Research on Neuroimmunological Diseases (CIEN) at the Raul Carrea Institute for Neurological Research (FLENI) in Argentina, Quintana and his colleagues began by studying patients. The team found that during the fall and winter, the group of 139 relapsing remitting MS patients they studied experienced a significant improvement in symptoms (a phenomenon that's been observed in previous studies). The team then explored a variety of environmental factors that have been proposed as possibly linked to MS symptoms, including vitamin D levels, UV incidence and upper respiratory tract infections. But the factor that was consistently associated with severity of MS symptoms was melatonin. Melatonin levels are known to correlate with day length - during the longer days of the spring and summer, levels are lower and during the shorter days of the fall and winter, levels are higher.

Based on this observation, the team tested this lead in the lab, studying the role that melatonin may play on a cellular level. Using both a mouse model and human cells, they investigated the effects of melatonin on certain types of cells, known to play a role in the immune response that leads to MS symptoms. The team found that melatonin affected the roles of two kinds of cells that are important in MS disease progression: pathogenic T cells that directly attack and destroy tissue and regulatory T cells, which are supposed to keep pathogenic T cells in check.

"We found that melatonin has a protective effect," said Quintana. "It dampens the immune response and helps keep the bad guys - or pathogenic T cells - at bay."

Although melatonin is available over the counter, it has significant drawbacks, including causing unwanted drowsiness. The team's goal is to tease apart the molecular mechanisms that underlie melatonin's role in order to develop targeted, non-toxic drugs that are safe and effective with minimal side effects.

"In the future, melatonin or its derivatives may be used in MS patients after appropriate clinical trials are conducted and dosage is established," said Quintana. "However, extreme caution should be exercised: our data do not show that melatonin or its analogs are effective in treating MS."

The team is currently working to establish a pilot clinical trial to study the effects of targeting melatonin signaling in MS patients and identify additional mechanisms of action.

INFORMATION:

This work was supported by the Allende Foundation and the MSIF Du-Preé grant, a grant from Biogen Idec and Novartis Argentina, Merck Serono Argentina, the National Institutes of Health (AI093903 and NS087867), National Multiple Sclerosis Society (RG4111A1 and JF2161-A-5), the International Progressive MS Alliance (PA0069).


ELSE PRESS RELEASES FROM THIS DATE:

Stanford scientists home in on origin of human, chimpanzee facial differences

2015-09-10
The face of a chimpanzee is decidedly different from that of a human, despite the fact that the apes are our nearest relative in the primate tree. Now researchers at the Stanford University School of Medicine have begun to pinpoint how those structural differences could arise in two species with nearly identical genetic backgrounds. The key lies in how genes involved in facial development and human facial diversity are regulated -- how much, when and where the genes are expressed-- rather than dissimilarities among the genes themselves. In particular, the researchers ...

Vision testing an effective tool for detecting concussion on the sidelines

2015-09-10
NEW YORK, NY - A timed vision test that involves rapidly reading numbers off of cards can be a valuable sideline tool for detecting whether a concussion occurred while playing sports, according to a meta-analysis and systematic review led by NYU Langone Medical Center concussion specialists. Researchers at the NYU Langone Concussion Center reviewed studies that involved athletes who sustained a concussion during sporting activities and found the vision test, known as the King-Devick test, was 86 percent sensitive in detecting whether a concussion had occurred, as confirmed ...

Solving a genetic mystery: Bridging diagnostic discovery through social media

2015-09-10
HOUSTON -- (Sept. 10, 2015) - "Help us find others like Tess." Bo Bigelow's plea jumps off the page of his blog, echoing across the continent from his leafy green home city of Portland, Maine. When he posted his call to action, all he knew was that his young daughter has a mutation in her USP7 gene and that she has global developmental delay, hip dysplasia and visual impairment caused by her brain (not a problem in her eyes themselves) among other health issues. An article in the New Yorker magazine by Seth Mnookin gave him hope that finding other children with the same ...

Pancreatic cancer stem cells could be 'suffocated' by an anti-diabetic drug

2015-09-10
Cancer cells commonly rely on glycolysis, the type of metabolism that does not use oxygen to generate their energy however, researchers from Queen Mary University of London's Barts Cancer Institute and the Spanish National Cancer Research Centre (CNIO) in Madrid have now found that not all cancer cells are alike when it comes to metabolism. PancSCs can make use of a more efficient form of metabolism, called oxidative phosphorylation or OXPHOS, which does use oxygen. OXPHOS uses a part of the cell called mitochondria and it is this which can be targeted with anti-diabetic ...

Discovery offers hope for treating leukemia relapse post-transplant

2015-09-10
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers. There is currently no effective treatment for this stage of leukemia, and patients have only a 5 percent chance of survival over five years. AML is a fast-moving cancer of the blood and bone marrow. In patients with AML, the bone marrow produces abnormal white or red blood cells or platelets. Powerful rounds of chemotherapy can damage bone marrow, so many patients are given ...

Researchers find neuroanatomical signature for schizophrenia

2015-09-10
While it is known that the incidence and outward symptoms of schizophrenia are strongly influenced by ethnic factors--for instance, patients from Asian ethnicities are more likely to experience visual hallucinations, whereas patients from western cultures and Caucasian ethnicities are more likely to suffer from auditory hallucinations--it was unclear if brain deficits would differ amongst suffers from various ethnic backgrounds. Previous research had indicated that there were neuroanatomical signatures for schizophrenia, but a study titled, "A Neuroanatomical Signature ...

Marginalized Vancouver residents dying at 8 times the national average

2015-09-10
Marginalized residents of Vancouver's Downtown Eastside are dying at more than eight times the national average, and treatable conditions are the greatest risk factors for mortality, researchers at the University of British Columbia have found. In research outlined in the British Medical Journal Open, investigators recruited 371 study participants aged 23 to 72 from single room occupancy hotels and the Downtown Community Court. Over the course of nearly four years, 31 participants died--a mortality rate 8.29 times the average for Canadians of the same age and sex. For ...

Moon's crust as fractured as can be

2015-09-10
Scientists believe that about 4 billion years ago, during a period called the Late Heavy Bombardment, the moon took a severe beating, as an army of asteroids pelted its surface, carving out craters and opening deep fissures in its crust. Such sustained impacts increased the moon's porosity, opening up a network of large seams beneath the lunar surface. Now scientists at MIT and elsewhere have identified regions on the far side of the moon, called the lunar highlands, that may have been so heavily bombarded -- particularly by small asteroids -- that the impacts completely ...

New protein manufacturing process unveiled

2015-09-10
Researchers from Northwestern University and Yale University have developed a user-friendly technology to help scientists understand how proteins work and fix them when they are broken. Such knowledge could pave the way for new drugs for a myriad of diseases, including cancer. The human body has a nifty way of turning its proteins on and off to alter their function and activity in cells: phosphorylation, the reversible attachment of phosphate groups to proteins. These "decorations" on proteins provide an enormous variety of function and are essential to all forms of life. ...

EARTH: Closing the gap in the tetrapod fossil record

2015-09-10
Alexandria, VA - In a study covered by EARTH Magazine, geoscientists identified fossils that are helping close the 15-million-year period in the fossil record known as Romer's Gap - the time from when fish showed early evidence of arms and legs until we definitively see four-legged land animals. Scientists have been wondering for decades whether Romer's Gap exists because tetrapod fossils from that time were not preserved, or because their fossils simply have not been discovered yet. These new fossils are starting to close the gap and change the way scientists interpret ...

LAST 30 PRESS RELEASES:

How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[Press-News.org] Melatonin and multiple sclerosis: Why MS symptoms may improve as the days get shorter
New research from Brigham and Women's Hospital offers an answer to the MS 'seasonal paradox'
Press-News.org is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.